Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer
- Mitsuo Sato
- , Masahiko Ando
- , Hironobu Minami
- , Yuichi Ando
- , Maki Ando
- , Masashi Yamamoto
- , Shuzo Sakai
- , Atsushi Watanabe
- , Takuya Ikeda
- , Yoshitaka Sekido
- , Hideo Saka
- , Kaoru Shimokata
- , Yoshinori Hasegawa
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
10
被引用数
(Scopus)